Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines
Product Brochure
Ondansetron Oral Solution IP
₹ 42/BoxGet Latest Price
Packaging Size
30 ml
Also Gives
PCD Pharma Franchise
Brand
Fymond
Shelf life
24
Medicine Type
Allopathic
Form
Syrup
Deals in
PCD Pharma
Grade
A1
Pacaging Type
Box
Forms
Drops
Country of Origin
Made in India
Availability
In Stock
Ondansetron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months.used in emergency situations to treat severe vomiting and diarrhea in children with acute gastroenteritis (stomach flu). It's also a drug commonly used to prevent severe nausea and vomiting in people undergoing cancer chemotherapy or radiation therapy.Ondansetron is a widely used 5HT3RA that, unlike alosetron, has not been associated with ischaemic colitis. A pilot randomised, placebo-controlled cross-over trial showed that 5 weeks of ondansetron was effective in improving diarrhoea and urgency.
Find products similar to Ondansetron Oral Solution IP
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
30-01-2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Mar 2023
GST
06AAMCR3120R1ZZ
Established in the year of 2023, We "Riqfame Critical Care Private Limited" are Wholesaler/Distributor And Manufacturer of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Syrup, Pharmaceutical Injection, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. For our accomplishment story, we are grateful to our Mr. Pratul Chauhan, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
